This inventor holds 5 USPTO granted patents and 4 published patent applications. Top assignee: Newave Pharmaceutical Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Yi Chen: Innovator in BCL-2 Inhibitors
Introduction
Yi Chen is a notable inventor based in Pleasanton, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target critical pathways in disease treatment. His work focuses on innovative solutions for neoplastic and autoimmune diseases.
Latest Patents
Yi Chen holds a patent for "1H-pyrrolo[2,3-b]pyridine derivatives as BCL-2 inhibitors for the treatment of neoplastic and autoimmune diseases." This invention relates to the synthesis and characterization of 1H-pyrrolo[2,3-b]pyridine derivatives and their potential as BCL-2 inhibitors. The patent includes detailed pharmacological data and examples that illustrate the efficacy of these compounds in treating various diseases.
Career Highlights
Yi Chen is currently associated with Newave Pharmaceutical Inc., where he applies his expertise in drug development. His work has been instrumental in advancing therapeutic options for patients suffering from challenging medical conditions. With 1 patent to his name, he continues to push the boundaries of pharmaceutical innovation.
Conclusion
Yi Chen's contributions to the field of pharmaceuticals highlight the importance of innovative research in developing effective treatments for serious diseases. His work exemplifies the impact that dedicated inventors can have on healthcare advancements.